MEKK2 inhibitor 1s

CAS No. ——

MEKK2 inhibitor 1s( MEKK2-IN-1s )

Catalog No. M16998 CAS No. ——

MEKK2 inhibitor 1s (MEKK2-IN-1s) is a potent MEKK2 (MAP3K2) inhibitor with IC50 of 16 nM, inhibits MEKK2 and MEKK3 with similar potencies.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MEKK2 inhibitor 1s
  • Note
    Research use only, not for human use.
  • Brief Description
    MEKK2 inhibitor 1s (MEKK2-IN-1s) is a potent MEKK2 (MAP3K2) inhibitor with IC50 of 16 nM, inhibits MEKK2 and MEKK3 with similar potencies.
  • Description
    MEKK2 inhibitor 1s (MEKK2-IN-1s) is a potent MEKK2 (MAP3K2) inhibitor with IC50 of 16 nM, inhibits MEKK2 and MEKK3 with similar potencies; displays activity in cell-based assays in which it inhibited ERK5 pathway activation in cells and inhibited cell migration in a scratch assay.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MEKK2-IN-1s
  • Pathway
    MAPK/ERK Signaling
  • Target
    MEK
  • Recptor
    MEK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    338.363
  • Molecular Formula
    C19H18N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    (Z)-8-ethoxy-2-((4-hydroxy-2-methylphenyl)imino)-2H-chromene-3-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ahmad S, et al. Biochem Biophys Res Commun. 2018 Jan 29;496(1):205-211.
molnova catalog
related products
  • Trametinib DMSO solv...

    A potent and highly specific MEK1/2 inhibitor with IC50 of 0.92 nM/1.8 nM.

  • AS703026

    AS703026 (Pimasertib;MSC1936369B) is a potent, selective, allosteric, orally bioavailable MEK1/2 inhibitor.

  • GNE-3511

    GNE-3511 is a potent, selective, orally bioavailable, brain-penetrant dual leucine zipper kinase (DLK, MAP3K12) inhibitor with Ki of <0.5 nM.